Chia‐Yu Chu

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

Wen‐Hung Chung, Lieh-Bang Liou, C.C. Chu et al. · Proceedings of the National Academy of Sciences · 2005 · 1.3K citations

Life Sciences, Genetics, Immunology +12

Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study

Sylvia H. Kardaun, Peggy Sekula, L. Valeyrie‐Allanore et al. · British Journal of Dermatology · 2013 · 980 citations

Life Sciences, Dermatology, Internal Medicine +12

The SCFbeta -TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in Ikappa Balpha and beta -catenin and stimulates Ikappa Balpha ubiquitination in vitro

Jeffrey Winston, Peter R. Strack, Peggy Beer‐Romero et al. · Genes & Development · 1999 · 946 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +12

Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials

Emma Guttman‐Yassky, Henrique D. Teixeira, Eric L. Simpson et al. · The Lancet · 2021 · 543 citations

Life Sciences, Dermatology, Pharmacotherapy +13

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

Thomas Bieber, Eric L. Simpson, Jonathan I. Silverberg et al. · New England Journal of Medicine · 2021 · 453 citations · Full text

Medicine, Dermatology, Pharmacology +15